Aurora Cannabis Responds to False Claims by Investing.com with Strong Denial
Aurora Cannabis Denies False Allegations from Investing.com
On June 19, 2025, Aurora Cannabis Inc. issued an official statement denying two erroneous articles that appeared on Investing.com. These articles falsely claimed that the leading Canada-based medical cannabis company was involved in an acquisition of New Zealand-based MedLeaf Therapeutics and entered into a strategic partnership with MediPharm GmbH for the distribution of medical cannabis in Germany and other EU markets.
Background of the Incident
The misleading articles surfaced on June 18, 2025, prompting Aurora to swiftly clarify the situation. In a well-documented response, the company categorically denied any such agreements or negotiations with MedLeaf Therapeutics or MediPharm GmbH. Furthermore, Aurora confirmed that no internal discussions regarding these supposed partnerships had taken place and that the company had not released any statements pertaining to such transactions.
Company’s Reaction
In the wake of this misinformation, Aurora Cannabis emphasized the significance of accuracy in reporting and the potential negative impact that false information can have on its brand integrity. The company aims to uphold its reputation as a trustworthy player in the cannabis market and has initiated an investigation into the origins of the false reporting.
Topics Consumer Products & Retail）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.